Poster Presentations: Tuesday, November 2, 2010 |

Evaluating Clinical Predictors of Complications of Thoracentesis FREE TO VIEW

Imran Mohammed, MD; Supriya Maddirala, MD; Akram Khan, MD
Author and Funding Information

Oregon Health and Science University, Portland, OR

Chest. 2010;138(4_MeetingAbstracts):348A. doi:10.1378/chest.10230
Text Size: A A A
Published online


PURPOSE: To evaluate the clinical predictors of complications during thoracentesis and to understand the efficacy of ultrasound guidance.

METHODS: We retrospectively reviewed clinical and radiological characteristics of 446 patients who had thoracentesis done between Jan 2003 and Jan 2009 at Portland VAMC.

RESULTS: We found 446 patients, 412 (92.3%) male, mean age was 63.2 (SD ±7.5) yrs. Using Light’s criteria, 238 (53.4%) were transudative and 208 (46.6%) were exudative pleural effusions. Of all effusions, 386 (86.6%) were unilateral and 60 (13.4%) bilateral. Loculation was only found in 27 (6%) effusions. Among the common diagnosis, 136 had congestive heart failure, 125 pneumonia, 118 lung cancer, 33 cirrhosis and 34 others (empyema, post-surgical, metastatic cancers, lymphoma, breast cancer, renal failure, trapped lung, mesothelioma, pulmonary embolism and unknown diagnosis). Only 36 patients were on aspirin, one on aspirin and plavix, 9 were on low-molecular weight heparin at the time of thoracentesis. Mean INR was 1.3 (SD± 0.34) and mean platelet count was 182 (SD ±82). Sixteen(3.5%) complications were noted, all pneumothorax, only 12 required chest tube insertion. In univariate analysis, there was a significant difference in complication rate between ultrasound guidance (3/225) and clinical exam (13/221) method of thoracentesis (p-value 0.0075). Complication rate was significantly higher in therapeutic (14/105) as compared to diagnostic (1/340) thoracentesis (p-value < 0.0001). Complication rate was significantly higher in symptomatic patients (15/118) as compared to asymptomatic patients (1/328) (p value < 0.0001). Complication rate was also found significantly higher in exudative (13/208) as compared to transudative (3/238) effusions (p-value 0.003). No significant difference in complication rate was found in the following groups: anti-platelet therapy, diagnosis, INR and platelet count.

CONCLUSION: Incidence of pneumothorax was significantly lower in ultrasound-guided and diagnostic thoracentesis groups. Symptomatic patients had a significantly higher complication rate, as did patients with exudative pleural effusions.

CLINICAL IMPLICATIONS: Presence of symptoms, therapeutic thoracentesis and exudative effusion were predictors of complications during thoracentesis. Ultrasound guidance lead to a lower rate of complications and should be encouraged during every thoracentesis.

DISCLOSURE: Imran Mohammed, No Financial Disclosure Information; No Product/Research Disclosure Information

12:45 PM - 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543